← FDA DRUG APPROVALS

FDA NDA · NDA011771

ATHROMBIN-K

Sponsor: PHARM RES ASSOC

APPLICATION
NDA011771
TYPE
NDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ATHROMBIN-KDiscontinued
WARFARIN POTASSIUM 25MG · TABLET · ORAL
ATHROMBIN-KDiscontinued
WARFARIN POTASSIUM 5MG · TABLET · ORAL
ATHROMBINDiscontinued
WARFARIN SODIUM 10MG · TABLET · ORAL
ATHROMBIN-KDiscontinued
WARFARIN POTASSIUM 2MG · TABLET · ORAL
ATHROMBIN-KDiscontinued
WARFARIN POTASSIUM 10MG · TABLET · ORAL
ATHROMBINDiscontinued
WARFARIN SODIUM 5MG · TABLET · ORAL
ATHROMBINDiscontinued
WARFARIN SODIUM 25MG · TABLET · ORAL
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →